Financhill
Back

Beam Therapeutics Stock Predictions

Beam Therapeutics Stock Forecast

  • Over the next 52 weeks, Beam Therapeutics has on average historically fallen by 32.2% based on the past 3 years of stock performance.
  • Beam Therapeutics has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
  • Is Beam Therapeutics Stock Undervalued?
    The current Beam Therapeutics [BEAM] share price is $34.03. The Score for BEAM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • BEAM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Beam Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Beam Therapeutics has on average historically fallen by 32.2% based on the past 3 years of stock performance.

Beam Therapeutics Stock Rating

Sell
50
Beam Therapeutics (BEAM) is a Sell

Is Beam Therapeutics overpriced?

  • Beam Therapeutics has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Beam Therapeutics Stock Price History

Is BEAM stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BEAM is experiencing slight buying pressure.

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
beamtx.com

52-Week Data

52-Week High:
41.07
52-Week Low:
16.95

Prediction Charts

Market Cap:
2.77B
Price in USD:
34.03
Volume:
910.7K
Beta:
1.60

Technical Analysis

SMA50:
27.83
SMA100:
25.86
SMA200:
27.57
52-Wk Change:
-15.93%

Stock Predictions

  • Is Beam Therapeutics stock public?
    Yes, Beam Therapeutics is a publicly traded company.
  • What is the Beam Therapeutics stock quote today?
    The Beam Therapeutics stock price is 34.03 USD today.
  • How to buy Beam Therapeutics stock online?
    You can buy Beam Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-5 25.23 25.94 26.06 24.14
Feb-6 25.86 27.88 27.96 25.36
Feb-7 27.76 27.57 27.85 26.84
Feb-8 27.55 28.09 28.45 27.35
Feb-9 28.45 29.08 29.54 28.03
Feb-12 28.75 33.40 33.56 28.75
Feb-13 31.15 29.98 31.61 29.52
Feb-14 30.84 31.29 31.71 29.75
Feb-15 31.91 33.02 34.22 31.70
Feb-16 32.40 32.89 33.75 32.26
Feb-20 32.35 31.81 33.14 31.33
Feb-21 31.22 31.79 32.16 30.68
Feb-22 31.84 33.54 33.87 31.40
Feb-23 33.36 34.03 34.66 33.28

Beam Therapeutics Earnings

Beam Therapeutics Earnings Report: Per Share Beam Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Beam Therapeutics Forecast Revenue Growth

Beam Therapeutics Stock Analysis: Historical quarterly revenues per share for Beam Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.46 per share, and an increase next year of $0.35 per share.

* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.